Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |